Resumen
Introducción: la hospitalización de pacientes durante la pandemia de COVID-19 se incrementó de manera
importante, y evidenció las carencias de los sistemas de salud, que no respondieron de forma adecuada y eficiente.
Objetivo: determinar la evolución de pacientes hospitalizados durante la pandemia de COVID-19 en Perú. Métodos: investigación descriptiva, transversal, retrospectiva. Efectuada con una data de 115 306 pacientes, a quienes se valoró su última evolución, el ingreso a Unidad de Cuidados Intensivos, si recibieron oxígeno o ventilación,
fallecidos por COVID-19 y vacunación contra esta enfermedad, según los datos de la plataforma nacional de datos abiertos del Ministerio de Salud del Perú. Para analizar los datos se usaron frecuencias absolutas y relativas y para la asociación comparativa de variables, el chi cuadrado de homogeneidad con una significancia estadística de p < 0,01. Resultados: de los pacientes que ingresaron a Unidad de Cuidados Intensivos, que recibieron oxígeno y ventilación, el 51,1 %, 59,1 % y 44,9 %, respectivamente, fueron dados de alta. Del 28,3 % de pacientes que fallecieron, el 90,2 % fue por COVID-19. La mayor proporción fueron adultos (51,1 %) y adultos mayores (31,2 %), de los cuales el 36,3 % y 62,4 % fallecieron por COVID-19. De los fallecidos por COVID-19, el 96,9 % no tenía ninguna dosis de vacuna contra la enfermedad. Conclusión: más de la mitad de los pacientes que ingresaron a Unidad de Cuidados Intensivos y recibieron oxígeno fueron dados de alta, la mayoría de los fallecidos por COVID-19 fueron adultos, adultos mayores y no vacunados. Las diferencias entre todos los pares de variables comparadas fueron altamente significativas (p < 0,001).
Referencias
Parotto M, Myatra SN, Munblit D, Elhazmi A, Ranzani OT, Herridge MS. Recovery after prolonged ICU treatment in patients with COVID-19. Lancet Respir Med. 2021; 9(8): 812-814. doi: 10.1016/S2213-2600(21)00318-0
Pasquini Z, Montalti R, Temperoni C, Canovari B, Mancini M, Tempesta M, et al. Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU. J Antimicrob Chemother. 2020; 75(11): 3359-3365. doi: 10.1093/jac/dkaa321
Nachtigall I, Lenga P, Jóźwiak K, Thürmann P, Meier-Hellmann A, Kuhlen R, et al. Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study. Clin Microbiol Infect. 2020; 26(12): 1663-1669. doi: 10.1016/j.cmi.2020.08.011
Nasrullah A, Jayakrishnan T, Wedgeworth P, Mosley M, Vashistha K, Haag A, et al. Characteristics and outcomes of COVID-19 patients admitted to Intensive Care Units in a large health system in Western Pennsylvania. Cureus. 2021; 13(7): e16552. doi: 10.7759/cureus.16552
Kocayiğit H, Özmen Süner K, Tomak Y, Demir G, Kocayiğit I, Yaylacı S, et al. Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study. Turk J Med Sci. 2021 ;51(2): 440-447.doi: 10.3906/sag2005-57
Roedl K, Jarczak D, Thasler L, Bachmann M, Schulte F, Bein B, et al. Mechanical ventilation and mortality among 223 critically ill patients with coronavirus disease 2019: A multicentric study in Germany. Aust Crit Care. 2021; 34(2): 167-175. doi: 10.1016/j.aucc.2020.10.009
Alharthy A, Aletreby W, Faqihi F, Balhamar A, Alaklobi F, Alanezi K, et al. Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: A Retrospective Study. J Epidemiol Glob Health. 2021; 11(1): 98-104.doi: 10.2991/jegh.k.200928.001
Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, et al. The impact of vaccination on COVID-19 outbreaks in the United States. Clin Infect Dis. 2021; ciab079. doi: 10.1093/cid/ciab079
Glatman-Freedman A, Bromberg M, Dichtiar R, Hershkovitz Y, Keinan-Boker L. The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data. EBioMedicine. 2021; 72: 103574. doi: 10.1016/j.ebiom.2021.103574
Victora C, Castro MC, Gurzenda S, Medeiros AC, França GVA, Barros AJD. Estimating the early impact of vaccination against COVID-19 on deaths among elderly people in Brazil: Analyses of routinely-collected data on vaccine coverage and mortality. EClinicalMedicine. 2021; 38: 101036. doi: 10.1016/j.eclinm.2021.101036
Díaz-Vélez C, Urrunaga-Pastor D, Romero-Cerdán A, Peña-Sánchez ER, Fernández JL, Cossio JD, et al. Risk factors for mortality in hospitalized patients with COVID-19 from three hospitals in Peru: a retrospective cohort study. F1000Res. 2021; 10: 224.doi: 10.12688/f1000research.51474.1
Mejía F, Medina C, Cornejo E, Morello E, Vásquez S, Alave J, et al. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One. 2020; 15(12): e0244171. doi: 10.1371/journal.pone.0244171
Solís JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, et al. COVID-19 vaccine acceptance and hesitancy in low- and middleincome countries. Nat Med. 2021; 27(8): 1385-1394. doi: 10.1038/s41591-021-01454-y
Aleem A, Akbar AB, Slenker AK. Emerging variants of SARS-CoV-2 and novel therapeutics against Coronavirus (COVID-19). StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. https://www.ncbi.nlm.nih.gov/books/NBK570580/
Ministerio de Salud. Hospitalizados, vacunados y fallecidos por COVID-19. Lima: MINSA; 2021. https://www.datosabiertos.gob.pe/dataset/hospitalizados-vacunados-y-fallecidos-porcovid-19
Gasmi A, Peana M, Pivina L, Srinath S, Benahmed A, Semenova Y, et al. Interrelations between COVID-19 and other disorders. Clin Immunol. 2021; 224: 108651. doi: 10.1016/j.clim.2020.108651
Daher A, Balfanz P, Cornelissen C, Müller A, Bergs I, Marx N, et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med. 2020; 174: 106197. doi. 10.1016/j.rmed.2020.106197
Tverring J, Åkesson A, Nielsen N. Helmet continuous positive airway pressure versus highflow nasal cannula in COVID-19: a pragmatic randomised clinical trial (COVID HELMET). Trials. 2020; 21(1): 994. doi: 10.1186/s13063-020-04863-5
Kim L, Garg S, O’Halloran A, Whitaker M, Pham H, Anderson EJ, et al. risk factors for Intensive Care Unit admission and in-hospital mortality among hospitalized adults identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVIDNET). Clin Infect Dis. 2021; 72(9): e206-e214. doi: 10.1093/cid/ciaa1012
Vences MA, Pareja-Ramos JJ, Otero P, VeramendiEspinoza LE, Vega-Villafana M, Mogollón-Lavi J, et al. Factors associated with mortality in patients hospitalized with COVID-19: A prospective cohort in a Peruvian national referral hospital. Medwave. 2021; 21(6): e8231. doi: 10.5867/medwave.2021.06.8231
Hueda-Zavaleta M, Copaja-Corzo C, Bardales-Silva F, Flores-Palacios R, Barreto-Rocchetti L, BenitesZapata VA. Factors associated with mortality due to COVID-19 in patients from a public hospital in Tacna, Peru. Rev Perú Med Exp Salud Pública. 2021; 38(2): 214-223. doi: http://dx.doi.org/10.17843/rpmesp.2021.382.7158
Gao YD, Ding M, Dong X, Zhang JJ, Kursat A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021; 76(2): 428-455. doi: 10.1111/all.14657
Varona L, Gonzales JR. Dynamics of the impact of COVID-19 on the economic activity of Peru. PLoS One. 2021; 16(1): e0244920. doi: 10.1371/journal.pone.0244920
Schwalb A, Seas C. The COVID-19 Pandemic in Peru: What went wrong? Am J Trop Med Hyg. 2021; 104(4): 1176-1178. doi: 10.4269/ajtmh.20-1323
Neyra-León J, Huancahuari-Nuñez J, Díaz-Monge JC, Pinto JA. The impact of COVID-19 in the healthcare workforce in Peru. J Public Health Policy. 2021; 42(1): 182-184. doi: 10.1057/s41271-020-00259-6
Curi-Quinto K, Sánchez A, Lago-Berrocal N, Penny ME, Murray C, Nunes R, et al. Role of government financial support and vulnerability characteristics associated with food insecurity during the COVID-19 Pandemic among Young Peruvians. Nutrients. 2021; 13(10): 3546. doi: 10.3390/nu13103546
Ministerio de Salud. Tiempos de pandemia 2020 –2021. Lima: MINSA; 2021. Disponible en: http://bvs.minsa.gob.pe/local/MINSA/5485.pdf
Cárcamo PM, Laca-Barrera M, Cabanillas-Silva D, Málaga-Rodríguez G, Mallma-Salazar P, Moore D, et al. Feasibility of noninvasive positive pressure ventilation in the treatment of oxygen-dependent COVID-19 Patients in Peru. Am J Trop Med Hyg. 2021; 105(3): 727-730. doi: 10.4269/ajtmh.21-0363
Huamaní C, Velásquez L, Montes S, MayangaHerrera A, Bernabé-Ortiz A. SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study. PeerJ. 2021; 9: e12149. doi: 10.7717/peerj.12149
Moreira-Soto A, Pachamora JM, González-Auza L, Merino XJ, Schwalb A, Drosten C, et al. High SARSCoV-2 Seroprevalence in rural Peru, 2021: a Crosssectional population-based study. mSphere. 2021; 6(6): e0068521. doi: 10.1128/mSphere.00685-21
Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021; 21(1): 39-51. doi: 10.1016/S1473-3099(20)30831-8
Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020; 383(25): 2439-2450. doi: 10.1056/NEJMoa2027906
Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C. Omicron SARS-CoV-2 variant: What we know and what we don’t. Anaesth Crit Care Pain Med. 2021; 41(1): 100998. doi: 10.1016/j.accpm.2021.100998
Queen D. Another year another variant: COVID 3.0-Omicron. Int Wound J. 2022; 19(1): 5. doi: 10.1111/iwj.13739
Kannan SR, Spratt AN, Sharma K, Chand HS, Byrareddy SN, Singh K. Omicron SARS-CoV-2 variant: Unique features and their impact on preexisting antibodies. J Autoimmun. 2021; 126: 102779. doi: 10.1016/j.jaut.2021.102779
Wang Z, Fu Y, Guo Z, Li J, Li J, Cheng H, et al. Transmission and prevention of SARS-CoV-2. Biochem Soc Trans. 2020; 48(5): 2307-2316. doi: 10.1042/BST20200693
Cruwys T, Stevens M, Donaldson JL, Cárdenas D, Platow MJ, Reynolds KJ, et al. Perceived COVID-19 risk is attenuated by ingroup trust: evidence from three empirical studies. BMC Public Health. 2021; 21(1): 869. doi: 10.1186/s12889-021-10925-3
Organización Panamericana de la Salud y Consejo de Organizaciones Internacionales de las Ciencias Médicas. Pautas éticas internacionales para la investigación relacionada con la salud con seres humanos, 4ta ed. Ginebra: CIOMS; 2016. https://iris.paho.org/bitstream/handle/10665.2/34457/9789290360902-spa.pdf?sequence=5
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Derechos de autor 2022 José Ander Asenjo-Alarcón